COVID immunity gap could spell disaster for China — global health expert

COVID Immunity Gap Could Spell Disaster for China — Global Health Expert | GZERO World

China’s homegrown COVID vaccines were once crucial — but they're not as effective against omicron as mRNA jabs.

What's more, with with local cases near zero for the better part of the pandemic, most Chinese have no natural immunity. That could spell disaster for Beijing as omicron surges.

Yanzhong Huang, senior fellow for global health at the Council on Foreign Relations, warns that the highly transmissible new variant will make zero COVID harder and harder to sustain.

If China’s current strategy fails, it’s likely that Xi Jinping will have to pivot to one that favors living with the virus.

Watch Huang’s interview with Ian Bremmer on GZERO World: Omicron & the undoing of China's COVID strategy

More from GZERO Media

RPG-7 training of Ukrainian soldiers. November 17, 2024.
  • Adrien Vautier via Reuters Connect

People from different cultures often approach the same problem in different ways. We wondered — would an AI trained and tuned in China approach a complex geopolitical challenge differently than a model created and trained in Europe, or in the United States?

French President Emmanuel Macron speaks to the members of the media, after arriving by plane to attend the Gaza Peace Summit, in Sharm el-Sheikh, Egypt, October 13, 2025.
Yoan Valat/Pool via REUTERS

2: French President Emmanuel Macron rejected calls to resign as his fragile government faces two no-confidence votes this week.

Palestinian children look at rubble following Israeli forces' withdrawal from the area, after Israel and Hamas agreed on the Gaza ceasefire, in Khan Younis, in the southern Gaza Strip, October 10, 2025.
REUTERS/Ramadan Abed

Israel approved the Gaza ceasefire deal on Friday morning, bringing the ceasefire officially into effect. The Israeli military must withdraw its forces to an agreed perimeter inside Gaza within 24 hours, and Hamas has 72 hours to return the hostages.